ABO blood group, ABO mismatched transfusions and leukoreduction of transfusions in hemostatic resuscitation studies

Autor: Phuong-Lan Nguyen, Akua Asante, Majed Refaai, Neil Blumberg

Publikováno v: Frontiers in Bioengineering and Biotechnology, Vol 12 (2024)

Externí odkaz: https://doaj.org/article/6bd345215cd74df499855ae1820a7bdd

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

Autor: Flora, Peyvandi, Marie, Scully, Johanna A, Kremer Hovinga, Spero, Cataland, Paul, Knöbl, Haifeng, Wu, Andrea, Artoni, John-Paul, Westwood, Magnus, Mansouri Taleghani, Bernd, Jilma, Filip, Callewaert, Hans, Ulrichts, Christian, Duby, Dominique, Tersago, Majed, Refaai

Publikováno v: Peyvandi, Flora; Scully, Marie; Kremer Hovinga, Johanna Anna; Cataland, Spero; Knöbl, Paul; Wu, Haifeng; Artoni, Andrea; Westwood, John-Paul; Mansouri Taleghani, Magnus; Jilma, Bernd; Callewaert, Filip; Ulrichts, Hans; Duby, Christian; Tersago, Dominique (2016). Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. New England journal of medicine NEJM, 374(6), pp. 511-522. Massachusetts Medical Society MMS 10.1056/NEJMoa1505533
The New England journal of medicine
NEW ENGLAND JOURNAL OF MEDICINE
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

BACKGROUND Acquired thrombotic thrombocytopenic purpura (TTP) is caused by aggregation of platelets on ultralarge von Willebrand factor multimers. This microvascular thrombosis causes multiorgan ischemia with potentially life-threatening complication

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::063872941a19fa935edad4522d375c94